ISSN: 2157-7609
Mario N. Pellegatti
Preclinical drug development consultant
Drug Metabolism and Pharmacokinetics Department
GlaxoSmithKline
Italy
He is currently working as an DMPK and preclinical drug development consultant In the last years he had given seminars and educational presentations on subjects related to DMPK and preclinical drug development, and reviewed scientific documents including protocols, scientific publications and reports.
His research interest includes Drug development; pharmacokinetics ,metabolism, safety evaluation of metabolites; drug distribution; drug absorption and biopharmaceutics; toxicokinetics, bioequivalence